Catalio Capital Management, LP Q1 2025 Filing

Filed May 15, 2025

Portfolio Value

$411.1B

Holdings

37

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (37 positions)

#StockSharesValue% PortfolioType
1
BDXBECTON DICKINSON & CO
203,965$46.7B11.36%
2
SWTXSPRINGWORKS THERAPEUTICS INC
758,533$33.5B8.14%
3
BBIOBRIDGEBIO PHARMA INC
962,883$33.3B8.10%
4
EWEDWARDS LIFESCIENCES CORP
435,588$31.6B7.68%
5
ASNDASCENDIS PHARMA A/S
195,523$30.5B7.41%
6
CYTKCYTOKINETICS INC
585,812$23.5B5.73%
7
VCYTVERACYTE INC
762,225$22.6B5.50%
8
SNDXSYNDAX PHARMACEUTICALS INC
1,733,701$21.3B5.18%
9
LLYELI LILLY & CO
23,682$19.6B4.76%
10
ISRGINTUITIVE SURGICAL INC
36,499$18.1B4.40%
11
LIVNLIVANOVA PLC
381,648$15.0B3.65%
12
DNTHDIANTHUS THERAPEUTICS INC
763,471$13.8B3.37%
13
INSPINSPIRE MED SYS INC
85,877$13.7B3.33%
14
GPCRSTRUCTURE THERAPEUTICS INC
704,864$12.2B2.97%
15
SLNOSOLENO THERAPEUTICS INC
160,962$11.5B2.80%
16
QUREUNIQURE NV
830,325$8.8B2.14%
17
REGNREGENERON PHARMACEUTICALS
12,261$7.8B1.89%
18
SLNOSOLENO THERAPEUTICS INC
100,000$6.5B1.58%Call
19
SEPNSEPTERNA INC
1,024,245$5.9B1.44%
20
TARAPROTARA THERAPEUTICS INC
1,088,691$4.6B1.13%
21
ADPTADAPTIVE BIOTECHNOLOGIES COR
611,639$4.5B1.11%
22
MLTXMOONLAKE IMMUNOTHERAPEUTICS
114,616$4.5B1.09%
23
KROSKEROS THERAPEUTICS INC
389,384$4.0B0.97%
24
VIRVIR BIOTECHNOLOGY INC
611,608$4.0B0.96%
25
REPLREPLIMUNE GROUP INC
355,640$3.5B0.84%
26
ZBIOZENAS BIOPHARMA INC
295,148$2.3B0.57%
27
OMOUTSET MED INC
166,666$1.8B0.45%
28
ARQTARCUTIS BIOTHERAPEUTICS INC
100,000$1.3B0.30%Put
29
KYTXKYVERNA THERAPEUTICS INC
586,909$1.1B0.28%
30
MGXMETAGENOMI INC
528,993$719.4M0.17%
31
MERSANA THERAPEUTICS INC
1,705,036$586.9M0.14%
32
FULCFULCRUM THERAPEUTICS INC
202,139$582.2M0.14%
33
KPTIKARYOPHARM THERAPEUTICS INC
155,622$582.0M0.14%
34
HYPRHYPERFINE INC
760,035$544.4M0.13%
35
ATAIATAI LIFE SCIENCES NV
196,858$267.7M0.07%
36
GUTSFRACTYL HEALTH INC
214,236$254.9M0.06%
37
SNSEEURSENSEI BIOTHERAPEUTICS INC
294,374$116.0M0.03%